Nanjing Hanxin Pharmaceutical Technology Co., Ltd. – FDA Inspection, Mar 28, 2025

Record Details

This FDA Inspection record concerns Nanjing Hanxin Pharmaceutical Technology Co., Ltd., with an inspection on March 28, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Nanjing Hanxin Pharmaceutical Technology Co., Ltd.
Inspection Date: March 28, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Nicholas L. Hunt (FDA Associated Person)

View Company Profile

ID · 8ba09644-12e1-4719-889c-2d16748a4eea

Inspection Facts

Inspection number: 1269301
FDA center: Human Drugs
Outcome: Form 483 issued, view the record

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nanjing Hanxin Pharmaceutical Technology Co., Ltd.

FDA Inspection

Nanjing Hanxin Pharmaceutical Technology Co., Ltd.March 28, 2025